These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7894471)

  • 1. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid.
    Swaab DF; Raadsheer FC; Endert E; Hofman MA; Kamphorst W; Ravid R
    J Neuroendocrinol; 1994 Dec; 6(6):681-7. PubMed ID: 7894471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype.
    Liu RY; Zhou JN; van Heerikhuize J; Hofman MA; Swaab DF
    J Clin Endocrinol Metab; 1999 Jan; 84(1):323-7. PubMed ID: 9920102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression.
    Hoogendijk WJ; Meynen G; Endert E; Hofman MA; Swaab DF
    Neurobiol Aging; 2006 May; 27(5):780.e1-780.e2. PubMed ID: 16198445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress of dying is not suppressed by high-dose morphine or by dementia.
    Erkut ZA; Klooker T; Endert E; Huitinga I; Swaab DF
    Neuropsychopharmacology; 2004 Jan; 29(1):152-7. PubMed ID: 12955097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia.
    Wang LY; Raskind MA; Wilkinson CW; Shofer JB; Sikkema C; Szot P; Quinn JF; Galasko DR; Peskind ER
    Int J Geriatr Psychiatry; 2018 May; 33(5):763-768. PubMed ID: 29446123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
    Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM
    Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.
    Laske C; Stransky E; Fritsche A; Eschweiler GW; Leyhe T
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):80-5. PubMed ID: 18806919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.
    Nakano S; Kato T; Nakamura S; Kameyama M
    J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF cortisol in Alzheimer's disease and mild cognitive impairment.
    Popp J; Schaper K; Kölsch H; Cvetanovska G; Rommel F; Klingmüller D; Dodel R; Wüllner U; Jessen F
    Neurobiol Aging; 2009 Mar; 30(3):498-500. PubMed ID: 17716786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
    Appleyard ME; McDonald B
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.
    Tune L; Gucker S; Folstein M; Oshida L; Coyle JT
    Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis.
    Erkut ZA; Endert E; Huitinga I; Swaab DF
    Mult Scler; 2002 May; 8(3):229-36. PubMed ID: 12120695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia.
    Ferrari E; Arcaini A; Gornati R; Pelanconi L; Cravello L; Fioravanti M; Solerte SB; Magri F
    Exp Gerontol; 2000 Dec; 35(9-10):1239-50. PubMed ID: 11113605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CSF cortisol in AD is a function of APOE genotype.
    Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA
    Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
    Atack JR; May C; Kaye JA; Kay AD; Rapoport SI
    Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the Alzheimer type.
    Martignoni E; Petraglia F; Costa A; Monzani A; Genazzani AR; Nappi G
    J Clin Lab Anal; 1990; 4(1):5-8. PubMed ID: 2313466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels.
    Martignoni E; Petraglia F; Costa A; Bono G; Genazzani AR; Nappi G
    Acta Neurol Scand; 1990 May; 81(5):452-6. PubMed ID: 2375247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.